Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma.
Vairy S, Le Teuff G, Bautista F, De Carli E, Bertozzi AI, Pagnier A, Fouyssac F, Nysom K, Aerts I, Leblond P, Millot F, Berger C, Canale S, Paci A, Poinsignon V, Chevance A, Ezzalfani M, Vidaud D, Di Giannatale A, Hladun-Alvaro R, Petit FM, Vassal G, Geoerger B, Le Deley MC, Grill J. Vairy S, et al. Among authors: poinsignon v. Neurooncol Adv. 2020 Jun 9;2(1):vdaa075. doi: 10.1093/noajnl/vdaa075. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32666050 Free PMC article.
Pharmacokinetic interaction involving fenofibrate and everolimus.
Mir O, Poinsignon V, Arnedos M, Delaloge S, Paci A. Mir O, et al. Among authors: poinsignon v. Ann Oncol. 2015 Jan;26(1):248-249. doi: 10.1093/annonc/mdu492. Epub 2014 Oct 30. Ann Oncol. 2015. PMID: 25361989 Free article. No abstract available.
A case of melphalan sustained accumulation in an 80-year old patient.
Jolivot PA, Poinsignon V, Paci A, Guidet B, Pichereau C, Fernandez C, Hindlet P. Jolivot PA, et al. Among authors: poinsignon v. Int J Clin Pharm. 2015 Dec;37(6):984-7. doi: 10.1007/s11096-015-0197-x. Epub 2015 Sep 22. Int J Clin Pharm. 2015. PMID: 26394785
Busulfan after HSCT in children and young adults.
Paci A, Poinsignon V, Broutin S, Mir O, Vassal G. Paci A, et al. Among authors: poinsignon v. Lancet Haematol. 2017 Mar;4(3):e103. doi: 10.1016/S2352-3026(16)30189-2. Lancet Haematol. 2017. PMID: 28257751 No abstract available.
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours.
Hollebecque A, Bahleda R, Faivre L, Adam J, Poinsignon V, Paci A, Gomez-Roca C, Thery JC, Le Deley MC, Varga A, Gazzah A, Ileana E, Gharib M, Angevin E, Malekzadeh K, Massard C, Soria JC, Spano JP. Hollebecque A, et al. Among authors: poinsignon v. Eur J Cancer. 2017 Aug;81:81-89. doi: 10.1016/j.ejca.2017.05.021. Epub 2017 Jun 12. Eur J Cancer. 2017. PMID: 28618305 Clinical Trial.
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study.
Angevin E, Cassier PA, Italiano A, Gonçalves A, Gazzah A, Terret C, Toulmonde M, Gravis G, Varga A, Parlavecchio C, Paci A, Poinsignon V, Soria JC, Drubay D, Hollebecque A. Angevin E, et al. Among authors: poinsignon v. Eur J Cancer. 2017 Sep;83:194-202. doi: 10.1016/j.ejca.2017.06.036. Epub 2017 Jul 24. Eur J Cancer. 2017. PMID: 28750271 Clinical Trial.
New dosing nomogram and population pharmacokinetic model for young and very young children receiving busulfan for hematopoietic stem cell transplantation conditioning.
Poinsignon V, Faivre L, Nguyen L, Neven B, Broutin S, Moshous D, Bourget P, Dufour C, Dalle JH, Galambrun C, Devictor B, Kemmel V, De Berranger E, Gandemer V, Vannier JP, Jubert C, Bondu S, Mir O, Petain A, Vassal G, Paci A. Poinsignon V, et al. Pediatr Blood Cancer. 2020 Oct;67(10):e28603. doi: 10.1002/pbc.28603. Epub 2020 Jul 24. Pediatr Blood Cancer. 2020. PMID: 32706505
28 results